ABIN185354
antibody from antibodies-online
Targeting: AKAP9
AKAP350, AKAP450, CG-NAP, HYPERION, KIAA0803, LQT11, MU-RMS-40.16A, PPP1R45, PRKA9, YOTIAO
Antibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN185354 - Provider product page
- Provider
- antibodies-online
- Proper citation
- Antibodies-Online Cat#ABIN185354, RRID:AB_10781099
- Product name
- anti-A Kinase (PRKA) Anchor Protein (Yotiao) 9 (AKAP9) (C-Term) antibody
- Antibody type
- Polyclonal
- Description
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Reactivity
- Human
- Host
- Goat
- Epitope
- C-Term
- Vial size
- 100 μg
- Storage
- Aliquot and store at -20°C.
- Handling
- Minimize freezing and thawing.
Submitted references Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer.
Ciampi R, Knauf JA, Kerler R, Gandhi M, Zhu Z, Nikiforova MN, Rabes HM, Fagin JA, Nikiforov YE
The Journal of clinical investigation 2005 Jan;115(1):94-101
The Journal of clinical investigation 2005 Jan;115(1):94-101
No comments: Submit comment
No validations: Submit validation data